Triglycine has demonstrated nearly zero side-reaction performance in multiple enzymatic catalytic systems, bringing innovative solutions to tackle long-standing bottlenecks in biomanufacturing and carving out a new technical route for overall production-cost reduction. Composed of three successive glycine residues without reactive side-chain functional groups, triglycine avoids off-target modification sites that commonly trigger undesired side conversions during enzyme-driven biocatalysis. Unlike most peptide substrates carrying reactive amino, carboxyl, thiol or aromatic side groups, its molecular framework only retains backbone peptide bonds and terminal reactive sites recognised by target enzymes, which effectively restricts catalytic events to designated reaction loci and suppresses non-specific cross‑linking, random hydrolysis and aberrant coupling by‑products.
Such near-zero-side-reaction characteristics deliver direct economic benefits for downstream biomanufacturing workflows. When triglycine is used as enzyme substrate, spacer segment or recognition motif, the reaction system generates minimal complex impurities. The demand for multi-step fine purification is substantially decreased, cutting the consumption of separation media, solvent input and energy expenditure for repeated chromatographic processing. Lower by-product accumulation also improves the effective conversion ratio of raw materials, elevates target product yield, and reduces material loss caused by side-reaction degradation. In industrial-scale biocatalysis, these factors collectively compress comprehensive manufacturing costs, especially for high-value biopharmaceutical intermediates, site-specific bioconjugates and engineered peptide products.
Triglycine fits well with a wide spectrum of industrial enzymatic platforms. In sortase-A-mediated site-specific protein labelling and antibody modification, the triglycine sequence serves as the canonical acceptor substrate; the absence of side-chain reactivity prevents miscellaneous protein cross-linking and truncated conjugate impurities, simplifying the acquisition of homogeneous biomacromolecule products. In protease-catalysed peptide synthesis and fragment ligation systems, triglycine spacers guide enzymes to cleave and ligate at expected peptide-bond positions, eliminating random peptide fragmentation. Even under high-substrate-density industrial reaction conditions, its chemical inertness toward most biocatalytic moieties maintains reaction specificity, avoiding quality fluctuation induced by trace side impurities.
Apart from suppressing side reactions, triglycine possesses favourable physicochemical properties adapted to biomanufacturing. It exhibits good water-solubility under broad pH ranges, imposes low osmotic burden on enzymatic reaction systems, and will not precipitate out to interfere with catalytic efficiency. As a short natural oligopeptide, triglycine can be produced via microbial fermentation or low-cost chemical peptide synthesis, with accessible raw-material sources and relatively low reagent cost itself. Its moderate conformational flexibility further optimises enzyme-substrate binding affinity, supporting high catalytic rate without introducing extra steric-hindrance-related adverse effects.
Certain practical constraints still require rational consideration during process development. Although triglycine itself avoids side-chain-driven side reactions, excessive reaction time, extreme pH or temperature may trigger non-enzymatic backbone hydrolysis independent of enzyme catalysis. Process parameters must be finely tuned to match enzymatic optimum windows, so as to fully realise zero-side-reaction potential. In addition, triglycine functions primarily as recognition spacer or structural fragment; it cannot replace functional peptide segments that require specific side-chain groups for target biological activity.
Triglycine minimises enzymatic off-target conversion by virtue of side-chain-free molecular features, lowering impurity generation, simplifying downstream purification and improving raw-material utilisation efficiency. It provides a practical new pathway for cost control within biomanufacturing. With further optimisation of matching enzyme variants and reaction workflows, triglycine-based catalytic strategies will gain broader application prospects in industrial peptide preparation, biomacromolecule modification and biopharmaceutical intermediate manufacturing.
